# Weimin Li

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/weimin-li/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,150 |
| Field | Lung Cancer Diagnosis and Treatment |
| h-index | 74 |
| i10-index | 330 |
| Last Known Institution | Sichuan University |
| OpenAlex ID | https://openalex.org/A5100367626 |
| ORCID iD | 0000-0003-0985-0311 |
| Works | 815 |

## Researcher papers

Showing 12 of 16.

- [Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography](https://scholariq.org/papers/clinically-applicable-ai-system-for-accurate-diagnosis-quantitative-measurements/)
- [Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050](https://scholariq.org/papers/estimates-and-projections-of-the-global-economic-cost-of-29-cancers-in-204/)
- [Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease](https://scholariq.org/papers/evacetrapib-and-cardiovascular-outcomes-in-high-risk-vascular-disease/)
- [Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer](https://scholariq.org/papers/safety-and-feasibility-of-crispr-edited-t-cells-in-patients-with-refractory-non/)
- [A fully automatic deep learning system for COVID-19 diagnostic and prognostic analysis](https://scholariq.org/papers/a-fully-automatic-deep-learning-system-for-covid-19-diagnostic-and-prognostic/)
- [Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity](https://scholariq.org/papers/metabolic-reprogramming-of-terminally-exhausted-cd8-t-cells-by-il-10-enhances/)
- [Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)](https://scholariq.org/papers/efficacy-and-safety-of-sintilimab-plus-pemetrexed-and-platinum-as-first-line/)
- [The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial](https://scholariq.org/papers/the-third-intensive-care-bundle-with-blood-pressure-reduction-in-acute-cerebral/)
- [Telemedicine During the COVID-19 Pandemic: Experiences From Western China](https://scholariq.org/papers/telemedicine-during-the-covid-19-pandemic-experiences-from-western-china/)
- [COVID-19 in early 2021: current status and looking forward](https://scholariq.org/papers/covid-19-in-early-2021-current-status-and-looking-forward/)
- [New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study](https://scholariq.org/papers/new-onset-acute-symptomatic-seizure-and-risk-factors-in-coronavirus-disease-2019/)
- [Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis](https://scholariq.org/papers/acute-myocardial-injury-is-common-in-patients-with-covid-19-and-impairs-their/)

## Researcher topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Sichuan University](https://scholariq.org/institutions/sichuan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.